Baylor Scott & White Heart and Vascular Hospital – Fort Worth is actively recruiting for a study of cardiac contractility modulation (CCM) in a new group of heart failure patients. The AIM HIGHer study will evaluate the efficacy and safety of implantable CCM therapy in those with symptomatic heart failure and an ejection fraction (EF) between 40 and 60%.
The Valve Disorders Center at Baylor Scott & White Heart and Vascular Hospital – Fort Worth offers streamlined access to experts in valve disease for physicians and their patients. By bringing together a dedicated team from multiple specialties, including cardiothoracic surgeons on the medical staff of Baylor Scott & White All Saints Medical Center – Fort Worth, patients with valve disorders get a comprehensive evaluation and access to innovative treatments in one place.
The vascular program at Baylor Scott & White All Saints Medical Center – Fort Worth recently performed Tarrant County’s first fenestrated abdominal aortic aneurysm surgery, or FEVAR.
Alcohol-associated liver disease (ALD) is a major driver of liver-related morbidity and mortality across the world. There are 2.4 billion alcohol users (950 million heavy alcohol users) and between 1 in 10 and 1 in 20 people abuse or misuse alcohol. Combined, alcohol-associated cirrhosis and liver cancer account for 1 out of every 100 deaths worldwide.
Baylor Scott & White All Saints Medical Center – Fort Worth now offers comprehensive care for patients with advanced heart failure, including left ventricular support devices and other mechanical circulatory support. The advanced heart failure team implanted its first LVAD in July.
